Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

被引：0
|
作者：
Park, Sang Hyun
Kim, Yohan
Kim, Jung Kuk
Lee, Dahae
Park, Eunjin
Kim, Jeong A.
Hong, Sunghee
Choi, Jaehyuk
Bae, Sungmin
Lee, Sang Hyun
Choi, In Young
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-776-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
776-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Potent weight loss mechanism and improvement of NASH by the long-acting GLP-1/glucagon receptor dual agonist HM12525A
    Jung, S.
    Lee, J.
    Kim, J.
    Lee, Y.
    Kim, Y.
    Kang, J.
    Trautmann, M.
    Hompesch, M.
    Kwon, S.
    DIABETOLOGIA, 2015, 58 : S380 - S380
  • [32] Anti-fibrotic potential of a novel long-acting Glucagon/GIP/GLP-1 triple agonist (HM15211) in preclinical models of idiopathic pulmonary fibrosis
    Lee, S.
    Kim, J.
    Lee, J.
    Kim, J.
    Ban, Y. -H.
    Lee, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S431 - S431
  • [33] Anti-fibrotic Potential of a Novel Long-acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Idiopathic Pulmonary Fibrosis
    Kim, J.
    Kim, W.
    Lee, S.
    Lee, J.
    Kim, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] A novel combination of a long-acting GLP-1/GIP/Glucagon triple agonist and once weekly basal insulin offers improved glucose lowering and weight loss in diabetic animal model
    Lee, J.
    Kim, J.
    Choi, J.
    Jung, S.
    Lee, S.
    Choi, I.
    Kim, S.
    DIABETOLOGIA, 2018, 61 : S348 - S349
  • [35] Potential effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in preclinical model of cholestatic liver disease
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S417 - S417
  • [36] Novel Combination of a Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) and Once-Weekly Basal Insulin (HM12460a) Offers Improved Glucose Lowering and Weight Loss in a Diabetic Animal Model
    Kim, Jung Kuk
    Lee, Jong Suk
    Choi, Jaehyuk
    Jung, Sung Youb
    Lee, Sang Hyun
    Choi, In Young
    Kim, Sun Jin
    DIABETES, 2018, 67
  • [37] Potent weight loss effects and mechanism of a novel long-acting glucagon analogue, HM15136, in animal models
    Lee, J.
    Kim, J.
    Kim, J.
    Park, E.
    Lee, S. -H.
    Bae, S.
    Choi, I.
    DIABETOLOGIA, 2019, 62 : S378 - S378
  • [38] YH25723, a Novel Long-Acting GLP-1/FGF-21 Dual Agonist Provides More Potent and Sustained Glycemic Control and Greater Weight Loss Compared with Single Agonists in Animal Models
    Kim, Jun H.
    Choi, Hyun H.
    Kim, Dohoon
    Lim, Seyoung
    Seo, Minji
    Ju, Mi K.
    Park, Ju-Young
    Choi, Byung H.
    Kim, Jong G.
    Nam, Su Y.
    DIABETES, 2016, 65 : A270 - A270
  • [39] Potent Cholesterol Lowering Effect of the Novel Long-Acting GLP-1/Glucagon Dual Agonist (HM12525A)
    Jung, Sung Youb
    Park, Young Jin
    Lee, Jong Suk
    Kim, Eun Jung
    Lee, Young Mi
    Kim, Young Hoon
    Trautmann, Michael
    Kwon, Se-Chang
    DIABETES, 2016, 65 : A267 - A267
  • [40] Antifibrotic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in BDL-Induced Liver Fibrosis Mice
    Kim, Jung Kuk
    Lee, Jong Suk
    Kwon, Hyunjoo
    Lee, Jongsoo
    Kim, Daejin
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2020, 69
12345